Zeba Hussaini

Zeba Hussaini, MD serves as an Assistant Professor within the Department of Medicine, Division of Gastroenterology and Hepatology. Her academic work centers on clinical research at the intersection of metabolic liver disease and exercise physiology, with particular emphasis on nonalcoholic steatohepatitis (NASH) management.

Her primary research domains include:

• Gastroenterology and Hepatology
• Exercise Physiology interventions
• Metabolic disorder pathophysiology
• Nonalcoholic Steatohepatitis biomarkers
• COVID-19 vascular complications

Hussaini's publication trajectory (2021-2024) reveals a concentrated focus on exercise-based clinical trials for metabolic liver disease. Her work demonstrates methodological rigor through randomized controlled trials (AMPED study), biomarker investigations (FGF21 dynamics), and clinical case analyses (COVID-19/pulmonary embolism). Key thematic threads include dose-response relationships in aerobic training, biopsy-confirmed disease progression metrics, and vascular complications in viral infections. These studies consistently employ interdisciplinary approaches spanning hepatology, exercise science, and metabolic medicine.

With an h-index of 13 according to Scopus metrics, her research has gained significant traction, particularly the 2023 Nutrients publication on FGF21 which accumulated 10 SciVal citations. Her work appears in high-impact venues including Hepatology Communications, Nutrients, and the American Journal of the Medical Sciences, reflecting rigorous peer review standards and clinical relevance.